Innovation ecosystem

Search documents
Boston Scientific (NYSE:BSX) 2025 Earnings Call Presentation
2025-09-30 12:30
Relentless Innovation Enduring Growth Investor Day 2025 September 30, 2025 Welcome Video 2 Relentless Innovation Enduring Growth Welcome Lauren Tengler | Vice President, Investor Relations Safe harbor for forward-looking statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," " ...
AbbVie Inc. (ABBV) Presents at Goldman Sachs 46th Annual Global Healthcare Conference Transcript
Seeking Alphaยท 2025-06-11 05:36
Core Insights - AbbVie is actively engaging with the administration regarding drug pricing policies and is optimistic about the productive nature of these discussions [3][4]. Group 1: Company Overview - AbbVie is represented by its entire management team at the Goldman Sachs 46th Annual Global Healthcare Conference [1]. - Robert A. Michael, CEO & Director, emphasizes the importance of addressing affordability and access to medicines while maintaining innovation [4]. Group 2: Industry Environment - The pharmaceutical sector is currently facing uncertainties related to drug pricing policies, particularly following the Most Favored Nation Executive Order [3]. - The administration's engagement with the pharmaceutical industry is seen as a positive development, indicating a willingness to discuss various topics related to drug pricing and access [4].